Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DANAHER CORPORATION

(DHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DANAHER CORP /DE/ : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

05/13/2021 | 04:40pm EDT

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT

                 OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN 

OFFICERS



On May 12, 2021, the Board of Directors ("Board") of Danaher Corporation
("Danaher") increased the size of Danaher's Board from twelve to thirteen
members and appointed A. Shane Sanders to the Board to fill the newly-created
vacancy, with a term expiring at Danaher's 2022 annual meeting of shareholders.
Mr. Sanders was also appointed to the Audit Committee of the Board. As a
non-employee director, Mr. Sanders will receive the same compensation paid to
the other non-employee directors of Danaher as disclosed in Exhibit 10.26 to
Danaher's Annual Report on Form 10-K for the year ended December 31, 2020 (which
exhibit is incorporated by reference herein) including without limitation an
annual equity award. Mr. Sanders has also entered into a director
indemnification agreement with Danaher, the form of which is disclosed as
Exhibit 10.31 to Danaher's Annual Report on Form 10-K for the year ended
December 31, 2020 and which is incorporated by reference herein. In connection
with this appointment, the Board also determined that Mr. Sanders is independent
within the meaning of the listing standards of the New York Stock Exchange and
for purposes of Rule 10A-3(b)(1) under the Securities Exchange Act of 1934, as
amended ("Securities Exchange Act"), and also qualifies as an audit committee
financial expert as defined in Item 407(d)(5) of Regulation S-K under the
Securities Exchange Act.
There is no arrangement or understanding between Mr. Sanders and any other
person pursuant to which he was selected as a director of Danaher. There are no
transactions in which Mr. Sanders has an interest requiring disclosure under
Item 404(a) of Regulation S-K.


ITEM 9.01         FINANCIAL STATEMENTS AND EXHIBITS

              (c) Exhibits:

   Exhibit No.                         Description

       104                             Cover Page Interactive Data File

(formatted as inline XBRL with applicable

                                       taxonomy extension information contained in Exhibits 101)



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about DANAHER CORPORATION
07/28INSIDER TRENDS : Insider at Danaher Corp Acquires Stock Via Option/Derivative Se..
MT
07/27DANAHER : Unit, Cytiva Team Up to Invest $1.5 Billion to Expand Manufacturing Ca..
MT
07/27CYTIVA : and Pall Corporation investing 1.5 billion USD over two years to meet g..
PR
07/26DANAHER : Four Sustainability Kaizens Add Up to Savings
PU
07/26DANAHER CORP /DE/ : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/26DANAHER : Beckman Coulter to Distribute BNP Cardiac Assay to Customers
PR
07/23DANAHER : Goldman Sachs Adjusts Danaher's Price Target to $320 from $280, Keeps ..
MT
07/23DANAHER : JPMorgan Adjusts Danaher's Price Target to $310 from $280, Keeps Overw..
MT
07/23DANAHER : Wells Fargo Adjusts Danaher's Price Target to $320 from $290, Keeps Ov..
MT
07/23DANAHER : Baird Adjusts Danaher's Price Target to $305 From $270, Reiterates Out..
MT
More news